Table 2: Surgical complications and mortality.
| No. | Complications | Dindo-Clavien classification | Shunt occlusion (m) | Recurrent bleeding (m) | LT (m) | Follow-up (m) | Mortality |
| 1 | - | 15 | - | 44 | |||
| 2 | genital swelling | I | - | - | DDLT (3) | 43 | |
| 3 | - | 18 | 18 | 30 | |||
| 4 | PSE | II | - | - | 6 | + | |
| 5 | hemorrhoid | I | 4 | 4 | 19 | ||
| 6 | - | - | - | 13 | |||
| 7 | PSE | II | - | - | LDLT (6) | 13 | |
| 8 | - | 12 | - | 14 | |||
| 9 | liver failure | V | - | - | 0.5 | + | |
| 10 | - | - | - | ||||
| 11 | PSE | II | - | - | 2 |
m: Months after MFS; PSE: Portal-systemic encephalopathy; LTX: Liver transplantation; DDLT: Deceased donor liver transplantation; LDLT: Living donor liver transplantation.